Related Experiment Video
Updated: Jun 25, 2025

11:21
Bioparticle Microarrays for Chemotactic and Molecular Analysis of Human Neutrophil Swarming in vitro
Published on: February 16, 2020
5.1K
Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis
Ana C Maretti-Mira1, Matthew P Salomon1, Shefali Chopra2
1USC Research Center for Liver Diseases, Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Biomedicines
|May 25, 2024
Summary
Neutrophils in metabolic dysfunction-associated steatohepatitis (MASH) show increased activation and lifespan. As MASH progresses, immature neutrophils are released, potentially worsening liver inflammation and fibrosis.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Neutrophils are vital for host defense but can cause tissue damage through sterile inflammation.
- Neutrophil accumulation is linked to liver fibrosis and cirrhosis in metabolic dysfunction-associated steatohepatitis (MASH).
Purpose of the Study:
- To investigate the role of circulating neutrophils in MASH progression using transcriptomic analysis.
- To identify mechanisms by which neutrophils contribute to liver inflammation and fibrosis in MASH.
Main Methods:
- Transcriptomic analysis of circulating neutrophils from mild and advanced MASH patients and non-diseased controls.
- Comparison of gene expression profiles and neutrophil characteristics between MASH stages and controls.
Main Results:
- Circulating neutrophils in MASH patients exhibit an enhanced activated transcriptional program and prolonged lifespan compared to controls.
- A shift towards premature release of immature, pro-inflammatory neutrophils occurs with MASH progression.
- Immature neutrophils in advanced MASH may exacerbate hepatic inflammation and promote fibrosis.
Conclusions:
- Neutrophil activation and altered release dynamics are key features of MASH progression.
- Immature neutrophils may drive inflammation and fibrosis in advanced MASH, highlighting them as potential therapeutic targets.
- Understanding neutrophil behavior in MASH offers insights into liver disease pathogenesis.

